GLAPHIN

This brand name is authorized in Nigeria.

Active ingredients

The drug GLAPHIN contains one active pharmaceutical ingredient (API):

1	Ceftriaxone UNII 023Z5BR09K - CEFTRIAXONE SODIUM
	Ceftriaxone is an antibacterial for systemic use, a third-generation cephalosporin. It inhibits bacterial cell wall synthesis following attachment to penicillin binding proteins (PBPs) leading to bacterial cell lysis and death.
	Read more about Ceftriaxone

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-7381	Injection	GLAPHIN INJECTION INJ 1000 mg/10 mL 1VIAL+10MLSWFI	78 CMS-PP-238497 GLAPHIN INJECTION CEFTRIAXONE SODIUM CEFTRIAXONE SODIUM B4-7381 Drugs ANTIINFECTIVES FOR SYSTEMIC USE Imported Products 1VIAL+10MLSWFI Prescription Only Medicine (POM) 12/21/2021 GLACK PHARM. LIMITED, CHURCH STREET, IDUMOTA LAGOS LAGOS 2.34704E+12 ugoglac2017@gmail.com SYNCOM FORMULATION (INDIA) LIMITED, 256 - 257, SECTOR - 1 PITHAMPUR (DHAR) 454 775, INDIA, India	28/03/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01DD04	Ceftriaxone	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01D Other beta-lactam antibacterials → J01DD Third-generation cephalosporins
Discover more medicines within J01DD04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-7381